SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,530,318 | -17.8% | 2,957,063 | +10.4% | 0.00% | 0.0% |
| Q2 2023 | $6,725,065 | +252.9% | 2,679,309 | +146.0% | 0.00% | – |
| Q1 2023 | $1,905,716 | +94995.6% | 1,088,981 | +130.9% | 0.00% | – |
| Q4 2022 | $2,004 | -99.5% | 471,673 | +45.4% | 0.00% | – |
| Q3 2022 | $385,000 | +613.0% | 324,292 | +496.6% | 0.00% | – |
| Q2 2022 | $54,000 | -91.4% | 54,355 | -78.9% | 0.00% | – |
| Q1 2022 | $629,000 | -6.0% | 257,056 | +3.3% | 0.00% | – |
| Q4 2021 | $669,000 | -46.9% | 248,821 | -1.1% | 0.00% | – |
| Q3 2021 | $1,259,000 | -23.8% | 251,486 | +13.5% | 0.00% | – |
| Q2 2021 | $1,653,000 | +523.8% | 221,593 | +390.1% | 0.00% | – |
| Q1 2021 | $265,000 | +191.2% | 45,215 | +132.9% | 0.00% | – |
| Q4 2020 | $91,000 | +37.9% | 19,411 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | – | 19,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |